Heidi Crayton MD

Neuroimmunology/Multiple Sclerosis

Medical Director at MS Center of Greater Washington

8320 Old Courthouse RdSuite 400Vienna, VA 22182
Phone+1 703-226-4000
Fax+1 703-226-4010

Dr. Crayton is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Crayton's full profile Already have an account?

Education & Training

MedStar Health Georgetown UniversityResidency, Neurology, 1994 - 1997
Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 1993 - 1994
MCP-Hahnemann College of MedicineClass of 1993

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 1997 - 2028
DC State Medical License 1997 - 2013
MD State Medical License 1997 - 1998
PA State Medical License 1993 - 1994
National Board of Physicians and Surgeons Neurology

Clinical Trials

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
Completed
Phase 2
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Terminated
Phase 3

Publications & Presentations

PubMed

1 citations
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series.
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner
Frontiers in Immunology. 2025-01-01
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series.
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner
Frontiers in Immunology. 2025-01-01
2 citations
COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review.
Rahul H Dave, Heidi Crayton, Augusto Miravalle, Ming-Hui Tai, Kerri Wyse
Neurology and Therapy. 2024-12-01